On Stays Premium, Gen Z Bypasses Insurers, FDA Rethinks Psychedelics

September 16, 2026: Your daily rundown of health and wellness news, in under 5 minutes.

Today's top stories:

On refuses to discount shoes as Q2 sales rise 13.5% to $1B, betting product innovation can support margins that reached 65.4% Accenture survey finds Gen Z and Millennial trust in health insurers fell 10.5%, with 62% already using AI tools to choose a health plan FDA signals more flexibility in psychedelic trial design, opening alternative approaches to comparators, dosing, and approval timelines

More from Fitt:

Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, cu...